SCHEMBL21067451

SCHEMBL21067451

N[C@@H](COS(=O)(=O)Cc1ccccc1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPI P09923 1/20 0.51
PKM P14618 1/20 0.51
PTGS1 P23219 1/20 0.51
XIAP P98170 1/20 0.51
SLC7A5 Q01650 1/20 0.51
IDO1 P14902 2/20 0.49
SLC1A1 P43005 7/20 0.47
SLC1A3 P43003 6/20 0.47
SLC1A2 P43004 5/20 0.47
KMT2A Q03164 2/20 0.46
SLC1A5 Q15758 1/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA5A P35218 1/20 0.43
CA9 Q16790 1/20 0.43
KYNU Q16719 2/20 0.42
GRIK1 P39086 1/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4313869 1.00 ALPI (0.51) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL10916650 0.76 KMT2A (0.52) KMT2ACA1CA2CA5ACA9
SCHEMBL27801072 0.76 KMT2A (0.52) KMT2ACA1CA2CA5ACA9
SCHEMBL4990043 0.76 KMT2A (0.52) KMT2ACA1CA2CA5ACA9
SCHEMBL5171450 0.75 SLC7A5 (0.61) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL4430587 0.75 ALPI (0.56) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL6903089 0.74 KMT2A (0.46) KMT2ACA1CA2CA5ACA9
SCHEMBL9304777 0.74 KMT2A (0.53) KMT2ACA1CA2CA5ACA9
SCHEMBL10486338 0.73 KMT2A (0.49) KMT2ACA1CA2CA5ACA9
SCHEMBL31369963 0.73 ALPI (0.55) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed